Draper touts new bioprocessing method as ‘next big advance in CAR T-cell treatment’
Draper has designed a microfluidic transduction device (MTD) it claims will help CAR T-cell therapy developers lower costs, up efficiency – and potentially bring manufacturing to the patient’s bedside.